AI assistant
Sending…
PRECISION BIOSCIENCES INC — Director's Dealing 2019
Apr 3, 2019
34491_dirs_2019-04-03_b2cc2435-8235-4c04-b1da-f02c3c6c3751.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2019-04-01
Reporting Person: FMR LLC (See Remark 1)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-04-01 | Common Stock | C | 3279170 | — | Acquired | 3279170 | Indirect |
| 2019-04-01 | Common Stock | C | 409078 | — | Acquired | 3688248 | Indirect |
| 2019-04-01 | Common Stock | P | 50000 | $16 | Acquired | 3738248 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-04-01 | Series A Preferred Stock | $ | C | 7000000 | Disposed | Common Stock (3279170) | Indirect | |
| 2019-04-01 | Series B Preferred Stock | $ | C | 873253 | Disposed | Common Stock (409078) | Indirect |
Footnotes
F1: On April 1, 2019, in connection with the completion of the issuer's initial public offering, each 2.134686 shares of Series A Preferred Stock and Series B Preferred Stock converted into 1 share of Common Stock.
More from PRECISION BIOSCIENCES INC
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8
Regulatory Filings
2026
Mar 17
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19